BB.SHR-(Gnal-D18Mit9)/K |
serum insulin level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood insulin amount |
both |
84 days
| 25 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
opthalmic venous plexus |
0.0 |
0 |
|
ng/ml is unit |
|
70100 |
324 |
Crl:WI |
serum insulin level |
control condition |
Korkmaz-Ic?z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
blood insulin amount |
male |
112 days
| 10 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
|
102942 |
2783 |
GK/MolTac |
serum insulin level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood insulin amount |
female |
60 days
| 6 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
fasting insulin, non fasting insulin |
106917 |
3071 |
WKY/NMolTac |
serum insulin level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood insulin amount |
female |
240 days
| 9 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
fasting insulin, non fasting insulin |
106921 |
3071 |
DA/K |
serum insulin level |
control condition |
Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. |
blood insulin amount |
not specified |
196 days-224 days |
12 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
radioimmunoassay |
|
0.0 |
0 |
|
|
|
96847 |
1123 |
GK/MolTac |
serum insulin level |
control condition |
Korkmaz-Ic?z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
blood insulin amount |
male |
112 days
| 8 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
|
102943 |
2783 |
BB.SHR-(D6Rat184-D6Rat3)/K |
serum insulin level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood insulin amount |
both |
84 days
| 32 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
opthalmic venous plexus |
0.0 |
0 |
|
ng/ml is unit |
|
70099 |
324 |
GK/Jcl |
serum insulin level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood insulin amount |
male |
52 days
| 6 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
|
103937 |
2884 |
GK/MolTac |
serum insulin level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood insulin amount |
female |
240 days
| 11 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
fasting insulin, non fasting insulin |
106918 |
3071 |
GK/MolTac |
serum insulin level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood insulin amount |
female |
420 days
| 11 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
fasting insulin, non fasting insulin |
106919 |
3071 |
WKY/NMolTac |
serum insulin level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood insulin amount |
female |
60 days
| 6 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
fasting insulin, non fasting insulin |
106920 |
3071 |
WKY/NMolTac |
serum insulin level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood insulin amount |
female |
420 days
| 9 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
fasting insulin, non fasting insulin |
106922 |
3071 |
WOKW |
serum insulin level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. |
blood insulin amount |
female |
196 days-224 days |
12 |
serial mean |
0.0 |
mg/dl |
|
|
radioimmunoassay |
ophthalmic venous plexus |
0.0 |
0 |
Roche Cobas Mira Plus (Roche, Switzerland) |
average of measures taken at 196 days, 210 days and 224 days |
|
67919 |
251 |
Jcl:WI |
serum insulin level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood insulin amount |
male |
52 days
| 6 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
|
103936 |
2884 |
BB.SHR-(D4Got41-Tacr1)/K |
serum insulin level |
control condition |
Kloting N, et al., Obes Res 2005 Mar;13(3):589-95. |
blood insulin amount |
male |
224 days
| 20 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
ng/ml |
|
11938 |
227 |
BB.SHR-(D6Rat184-D6Rat3)/K |
serum insulin level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood insulin amount |
both |
84 days
| 46 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
opthalmic venous plexus |
0.0 |
0 |
|
ng/ml is unit |
|
12981 |
324 |
BB.WOKW-(D4Got41-Fabp1)/K |
serum insulin level |
control condition |
Kloting N, et al., Obes Res 2005 Mar;13(3):589-95. |
blood insulin amount |
male |
224 days
| 16 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
ng/ml |
|
11942 |
227 |
BB/OK |
serum insulin level |
control condition |
Kloting N, et al., Obes Res 2005 Mar;13(3):589-95. |
blood insulin amount |
male |
224 days
| 20 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
ng/ml |
|
67939 |
227 |
DA/K |
serum insulin level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. |
blood insulin amount |
female |
196 days-224 days |
12 |
serial mean |
0.0 |
mg/dl |
|
|
radioimmunoassay |
ophthalmic venous plexus |
0.0 |
0 |
Roche Cobas Mira Plus (Roche, Switzerland) |
average of measures taken at 196 days, 210 days and 224 days |
|
67920 |
251 |
WOKW/K |
serum insulin level |
control condition |
Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. |
blood insulin amount |
not specified |
196 days-224 days |
12 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
radioimmunoassay |
|
0.0 |
0 |
|
|
|
96846 |
1123 |